Fluxid Approval History
- FDA approved: Yes (First approved September 24th, 2004)
- Brand name: Fluxid
- Generic name: famotidine
- Dosage form: Orally Disintegrating Tablets
- Company: Schwarz Pharma, Inc.
- Treatment for: Duodenal Ulcer, Stomach Ulcer, GERD, Zollinger-Ellison Syndrome
Fluxid (famotidine orally disintegrating tablets) is a histamine H2-receptor antagonist indicated for the treatment of ulcers, gastroesophageal reflux disease and pathological hypersecretory conditions.
Development History and FDA Approval Process for Fluxid
|Sep 24, 2004||Fluxid Schwarz Pharma, Inc. - Treatment for Ulcers and other Gastrointestinal Conditions|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.